Phase 2/3 Randomized Controlled Trial of Remestemcel-L in 300 Patients With COVID-19 Acute Respiratory Distress Syndrome Begins Enrollment

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access